Pharmidex attending Biowales 2015
March 4, 2015

Leading event for Life sciences sector in Wales between 4th & 5th March 2015

BioWales 2015 - 4th & 5th March 2015

The leading event for the life sciences sector in Wales this year will focus on the life sciences supply chain providing practical commercial opportunities for growth through novel routes to market in the private sector and NHS.


An international line-up of speakers and industry experts will deliver keynote addresses and lead the showcase presentations and discussions around supply chain opportunities and development. 


The showcase sessions will provide the opportunity to hear from the big names, present your ideas, products and plans and engage in the wider debate. Key themes will focus on commercialisation and routes to market, together with financing the deal. 


BioWales 2015 sees the return of a highlight from last year’s conference – the Dragon’s Den style pitches showcasing innovative new business ideas face to face with expert investors.


For more information please see: https://biowales.com/en/.

May 8, 2025
At Pharmidex, we are proud to contribute to scientific innovation through robust and reliable bioanalytical support from early discovery to regulated studies. For over eight years, we've partnered with Shimadzu, using their LCMS-8060 and LC-2050 systems to deliver high-quality, data-driven results tailored to diverse client needs. Their instruments have played a key role in advancing our bioanalytical capabilities and supporting the success of our collaborative projects. Our Head of Operations, Ash Alavijeh , recently shared insights from our long-standing collaboration as part of Shimadzu’s 150th anniversary testimonial series. We are honored to be part of their journey and look forward to continuing this partnership built on shared values of precision, reliability, and innovation. 👉 Read more stories from the Shimadzu global community here .
May 7, 2025
At Pharmidex, we stand in solidarity with individuals and families affected by Huntington’s Disease a rare, inherited neurodegenerative condition that impacts the mind, body, and spirit. Throughout May, we reaffirm our commitment to advancing neuroscience research and supporting drug discovery efforts aimed at neurodegenerative diseases. Our team is proud to collaborate with partners working toward meaningful therapies that can improve quality of life and bring hope to the HD community. Let’s raise awareness. Let’s drive innovation. Let’s stand together.
C3 Summit London
May 5, 2025
We’re pleased to share that Mo Yaqoob from our Business Development team will be attending the C3 Summit on 8 May 2025 at 8 Northumberland Ave, London. 🔗 https://www.thec3summit.com/london-2025/  Mo is looking forward to meeting fellow attendees, exploring new partnerships, and discussing how we can work together to accelerate the development of innovative drug candidates. If you're attending, don’t hesitate to connect let’s spark the next great collaboration!
More Posts